课题基金 / 基金详情

CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI

CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI
临床试验：DIMEBON 在轻度至中度 HUNTI 患者中的 3 期研究
批准号：
8166885
负责人：
JODY COREY-BLOOM
金额：
$0.64万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-12-01 至 2010-06-30
来源：
https://reporter.nih.gov/project-details/8166885
关键词：
CaregiversClinical TrialsCognitionComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionInterviewMeasuresPatientsPlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthbasedimebolinimpressionmental statephase 3 study

项目摘要

项目成果

JODY COREY-BLOOM的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the effect of Dimebon as compared to placebo on cognition as measured by the Mini-Mental State Examination (MMSE); and determine the effect of Dimebon as compared to placebo on the primary measure of global function, the Clinician's Interview-Based Impression of Change, plus caregiver input (CIBIC-plus).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE
CLINICAL TRIAL: ACR16 VERSUS PLACEBO FOR THE SYMPTOMATIC TREATMENT OF HUNTINGTON
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE
海外基金